Stock Research for BIO

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BIO Stock Chart & Research Data

The BIO chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BIO chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BIO Due diligence Resources & Stock Charts

The BIO stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BIO Detailed Price Forecast - CNN Money CNN View BIO Detailed Summary - Google Finance
Yahoo View BIO Detailed Summary - Yahoo! Finance Zacks View BIO Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View BIO Trends & Analysis - Trade-Ideas Barrons View BIO Major Holders - Barrons
NASDAQ View BIO Call Transcripts - NASDAQ Seeking View BIO Breaking News & Analysis - Seeking Alpha
Spotlight View BIO Annual Report - CompanySpotlight.com OTC Report View BIO OTC Short Report - OTCShortReport.com
TradeKing View BIO Fundamentals - TradeKing Charts View BIO SEC Filings - Bar Chart
WSJ View Historical Prices for BIO - The WSJ Morningstar View Performance/Total Return for BIO - Morningstar
MarketWatch View the Analyst Estimates for BIO - MarketWatch CNBC View the Earnings History for BIO - CNBC
StockMarketWatch View the BIO Earnings - StockMarketWatch MacroAxis View BIO Buy or Sell Recommendations - MacroAxis
Bullish View the BIO Bullish Patterns - American Bulls Short Pains View BIO Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View BIO Stock Mentions - StockTwits PennyStocks View BIO Stock Mentions - PennyStockTweets
Twitter View BIO Stock Mentions - Twitter Invest Hub View BIO Investment Forum News - Investor Hub
Yahoo View BIO Stock Mentions - Yahoo! Message Board Seeking Alpha View BIO Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for BIO - SECform4.com Insider Cow View Insider Transactions for BIO - Insider Cow
CNBC View BIO Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BIO - OTC Markets
Yahoo View Insider Transactions for BIO - Yahoo! Finance NASDAQ View Institutional Holdings for BIO - NASDAQ


Stock Charts

FinViz View BIO Stock Insight & Charts - FinViz.com StockCharts View BIO Investment Charts - StockCharts.com
BarChart View BIO Stock Overview & Charts - BarChart Trading View View BIO User Generated Charts - Trading View




Latest Financial News for BIO


What You Must Know About Bio-Rad Laboratories Inc’s (NYSE:BIO) Financial Health
Posted on Friday September 14, 2018

Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like Bio-Rad Laboratories Inc (NYSE:BIO), with a market cap of US$9.22b, are often out of theRead More...


Bio-Rad (BIO) Down 0.3% Since Last Earnings Report: Can It Rebound?
Posted on Thursday September 06, 2018

Bio-Rad (BIO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.


Bio-Rad to Participate at the Morgan Stanley 16th Annual Global Healthcare Conference on September 12
Posted on Wednesday August 29, 2018

Bio-Rad Laboratories, Inc. , a global leader of life science research and clinical diagnostic products, today announced that Norman Schwartz, President and CEO, and Christine Tsingos, Executive Vice President and CFO, will participate in a fireside chat at the Morgan Stanley 16th Annual Global Healthcare Conference on Wednesday September 12, at 1:40 PM , at The Grand Hyatt New York, New York City.


Here's Why You Should Steer Clear of AmerisourceBergen Now (Revised)
Posted on Friday August 24, 2018

AmerisourceBergen (ABC) continues to witness headwinds due to slowdown in hepatitis C revenues and conversion of branded drugs to the lower price generics.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.